Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The case for more money comming

"The fact that insiders are able to trade now is IMO based on the fact that the settlement is based on the USPTO decision which at this point in time is uncertain. It also explains why no money from the J's is reported in the 10Q because the USPTO decision on patent validity is uncertain at this point in time."

While this theory feels promising, what has actually changed? From the outset of the resolution, the company restricted stock transactions until the financials for the qtr. were released.......Something to consider.........

Share
New Message
Please login to post a reply